Ticking boxes. One day the mkt will notice.
"Second Ghent study demonstrates DOPlify™ suitability for liquid biopsy applications Highlights Second University of Ghent study published demonstrating DOPlify™ is internationally competitive for cell-based liquid biopsy applications New results reinforce the earlier Ghent study published in July 2017 that DOPlify™ is a world leading Whole Genome Amplification kit
RHS Price at posting:
14.0¢ Sentiment: None Disclosure: Held
